-+ 0.00%
-+ 0.00%
-+ 0.00%

Jefferies Downgrades IGM Biosciences to Hold, Lowers Price Target to $2

Benzinga·01/10/2025 17:50:02
Listen to the news
Jefferies analyst Roger Song downgrades IGM Biosciences (NASDAQ:IGMS) from Buy to Hold and lowers the price target from $48 to $2.